Mifepristone improves chemo-radiation response in glioblastoma xenografts

BACKGROUND: We have investigated the ability of Mifepristone, an anti-progestin and anti-glucocorticoid drug, to modulate the antitumor effect of current standard clinical treatment in glioblastoma xenografts. METHODS: The effect of radiation alone or combined with Mifepristone and Temozolamide was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Llaguno-Munive, Monserrat, Medina, Luis Alberto, Jurado, Rafael, Romero-Piña, Mario, Garcia-Lopez, Patricia
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3626552/
https://ncbi.nlm.nih.gov/pubmed/23530939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-13-29
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars